The 2024 American College of Rheumatology (ACR) annual meeting spotlighted transformative advancements in cell therapies for autoimmune diseases, with chimeric antigen receptor (CAR)-T therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback